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Abstract. Ellagitannins possess a wide range of biological activities and remarkable structural diversity, 
which commonly include an axially chiral biaryl unit. This paper describes syntheses of all-methylated 
versions of isorugosin B and rugosin B, which are regioisomeric, ellagitannin-related compounds. The 
key features of these syntheses involve the construction of an axially chiral biaryl function on a sugar 
moiety through a Pd-catalyzed intramolecular biaryl coupling reaction, Bringmann’s atroposelective 
lactone opening reaction, and a two-step ester formation. This is the first synthetic approach for 
generating ellagitannins featuring a valoneoyl group. 
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Introduction 
Ellagitannins are polyphenolic natural products with a wide range of biological activities, including 
antioxidant, antivirus, and antitumor activities. This class of compounds may therefore be useful in 
medicinal applications.1) Additionally, several researchers have expressed an interest in the structural 
diversity within this class of compounds with particular emphasis on those structures exhibiting axially 
chiral biaryl components.2) Effective methods for constructing axially chiral biaryl moieties have been 
developed3) and syntheses of several ellagitannins involving biaryl units with C2 symmetry, such as 
corilagin, sanguiin H-5, and coriariin A, have been demonstrated.4) However, non-symmetric biaryl 
components have yet to be synthesized. The valoneoyl group (Figure 1) is a significant structural 
component of ellagitannins 5) since the ellagitannins which possess this structure indicate unique 
bioactivity. In particular, oenothein B6) exhibits strong antitumor activity, based on potentiation of the 
host immune defense.7) For this reason, the development of efficient strategies for constructing 
valoneoyl groups is important for syntheses involving this class of natural ellagitannins in new drug 
discovery.  
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FIGURE 1. Examples of valoneoyl-containing ellagitannins and its related compounds. 
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The synthetic strategy described here is based on the initial construction of a valoneoyl group with 
subsequent attachment to a suitable glucose core. Trimethyl octa-O-methyl valonate (1), which has been 
frequently identified in structural determination of ellagitannins,5) was chosen as the initial synthetic 
target. Despite being an important structural component of the ellagitannin family, an asymmetric 
synthesis of 1 has not previously been reported.8) Axial chirality was generated using Bringmann’s 
‘lactone concept,’ which is an effective method for synthesizing axially chiral biaryl-type natural 
products.9) It was thus expected that this technique would be applicable to the synthesis of 
hexadecamethyl derivatives of isorugosin B (2)5d),5e) and rugosin B (3),5f) which are the corresponding 
regioisomeric ellagitannins.  
The current study demonstrates the first reported synthesis of valoneoyl-containing ellagitannins 
through the enantioselective construction of trimethyl octa-O-methyl valonate (1) and the syntheses of 
all-methylated versions of isorugosin B (2) and rugosin B (3).10) 
Results and Discussion 
Enantioselective Synthesis of Trimethyl Octa-O-Methyl Valonate 1. The initial synthetic outline of 
1 is depicted in Scheme 1. The target molecule 1 was synthesized from the six-membered ring lactone 4 
using Bringmann’s ‘lactone concept’ to forge the axially chiral biaryl components through a series of 
functional group manipulations. In this way, lactone 4 is a key intermediate in the synthesis. A Pd-
catalyzed intramolecular biaryl coupling reaction11) is presumably a useful method for the formation of 4, 
which requires ester 5 as a precursor. Ester 5 can be obtained by a simple esterification between the 
corresponding carboxylic acid 612) and phenol 7. Phenol 7 can be prepared by an Ullmann-type 
coupling13) of phenol 814) and bromide 9.15)  
 
SCHEME 1. Synthetic outline of 1. 
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The synthesis of 1 began with the preparation of the biaryl ether 10 through an Ullmann condensation 
of phenol 8,14) which was obtained from commercially available methyl gallate according to a previously 
reported method, and bromide 915) (Scheme 2). Deprotection under hydrogenolysis conditions provided 
phenol 7, which underwent esterification with carboxylic acid 612) using EDC to afford ester 5 as a 
precursor of the intramolecular biaryl coupling reaction. However, all attempts to prepare the coupling 
product 4 were unsuccessful. This result is similar to previous results,16) in which the electron-
withdrawing properties of the ester group adjacent to the reacting position interfered with the Pd-
mediated biaryl coupling reaction. 
 
SCHEME 2. Attempt to construct the six-membered ring lactone 4. 
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Accordingly, the ester group was converted to a carbinol or a protected carbinol, such as an 
acetoxymethyl or a siloxymethyl group. Converting the ester to an unprotected carbinol did not improve 
reactivity. In contrast, conversion to a protected carbinol provided the desired results; the best yields 
were obtained with the acetyl-protected carbinol. The synthesis of the six-membered lactone 14 is 
summarized in Scheme 3. Two ester groups in 10 were reduced with LiAlH4 and acetylated to yield the 
bis-acetoxymethyl compound 11, which was debenzylated to form phenol 12. Phenol 12 was condensed 
with carboxylic acid 6 using the same conditions as those in Scheme 2 to yield the coupling precursor 13. 
The intramolecular biaryl coupling reaction of 13 with Pd(OAc)2, Ph3P and NaOAc produced the 
desired lactone 14 in good yield.  
 
SCHEME 3. Construction of six-membered ring lactone 14. 
 
In the next stage, Bringmann’s lactone opening reaction was applied to 14 to construct the axially 
chiral biaryl components (Scheme 4). The asymmetric reduction of 14 with a borane-CBS reagent 
system17) succeeded in generating the optically active biaryl compound 15 in an enantiomerically pure 
form. The phenolic hydroxy group was subsequently methylated, and successive reduction of the two 
acetoxy groups produced the triol 17. A final two-step oxidation of three hydroxy groups and 
methylation of the resulting carboxylic acids gave compound 1. The absolute configuration of the 
synthetic material was determined by comparing the sign of optical rotation with that in previously 
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reported data.18) The stereoselectivity of the asymmetric reduction could be explained by the 
Bringmann’s model.9) The above procedure was successful in producing (S)-1.  
 
SCHEME 4. Synthesis of (S)-1. 
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Syntheses of Methylated Ellagitannins. Given the success of the above synthesis, the strategy was 
expanded to produce the ellagitannin regioisomers, isorugosin B and rugosin B. As discussed above, this 
class of ellagitannins has not been previously synthesized because of difficulties inherent in the 
construction of the valoneoyl group on the sugar moiety. However, the above strategy enabled a smooth 
conversion of the axially chiral valoneoyl group into all-methylated versions of isorugosin B (2) and 
rugosin B (3).  
The syntheses of 2 and 3 were relatively simple, as illustrated in Scheme 5. The most difficult step 
was the connection of the biaryl unit to the sugar moiety. This requires that two ester groups be formed 
in the final stage of the syntheses. In this context, the axially chiral biaryl compound 18 was the rational 
intermediate for regioselective esterification of glucose derivative 19.19) Although 18 can be obtained by 
a method analogous to that described above, the three ester groups in the valoneoyl group must be 
distinguishable from each other.  
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SCHEME 5. Synthetic outline of 2 and 3. 
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As depicted in Scheme 6, the synthesis started with the preparation of the biaryl ether by an Ullmann 
condensation between (siloxymethyl)phenol 20, which was obtained by LiAlH4 reduction and TBS 
protection of 8, and the bromide 9. Aldehyde 21 was isolated in 9% yield along with many other 
undesired by-products. It is likely that compound 20 underwent thermolysis of its silyl group, with 
subsequent auto-oxidation, to afford the formyl compound 22 as a reactive species. Thus, it was 
considered that 22 would be a suitable synthetic precursor for the formation of the biaryl ether. Based on 
this, 22 was synthesized from 8 by LiAlH4 reduction and Jones oxidation. The biaryl ether 21 was then 
obtained in good yield from the reaction of 22 and 9. Reduction of the formyl group and deprotection of 
the benzyl group provided the benzyl alcohol 23. Protection of the benzylic hydroxy group of 23 using a 
TBSCl-imidazole system succeeded in providing the desired phenol fragment 24. Phenol 24 was then 
coupled with carboxylic acid 6 to afford the ester 25. Ester 25 was then subjected to the intramolecular 
biaryl coupling reaction, using the same conditions as those in the previous scheme, to afford lactone 26. 
The lactone opening reaction of 26 proceeded smoothly under Bringmann’s conditions to generate the 
axially chiral biaryl compound 27 in high enantiomeric excess, which was methylated to afford the 
benzyl alcohol 28. The absolute configuration of the biaryl moiety was confirmed by a one-pot 
transformation of 28 to 17, and measurement of the optical rotation.20) Finally, a two-step oxidation 
(PDC oxidation and Pinnick oxidation21)) of (S)-28 resulted in the optically active carboxylic acid (S)-18 
as a key intermediate of the synthesis.  
 
SCHEME 6. Synthesis of key intermediate 18. 
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With the mono carboxylic acid (S)-18 in hand, an eleven-membered ring system was formed via a 
double esterification reaction between 18 and a glucose derivative (Scheme 7). Glucose derivatives 29 
and 32 were prepared from compound 19.22) The first attachment of 18 to 29, followed by selective 
desilylation of the primary alcohol, yielded the desired alcohol 30 as a single diastereoisomer, which 
was then oxidized to the ring-closing precursor, carboxylic acid 31. The final manipulation of 31 
consisted of removal of the TBS group with TBAF, and a subsequent intramolecular esterification under 
typical conditions to afford all-methylated isorugosin B (2). The moderate yield of this step may be due 
to the low reactivity of the secondary hydroxy group of the sugar. While the NMR spectrum of synthetic 
2 was identical to that of the authentic chart, significant differences were observed regarding the sign of 
optical rotation.23) This discrepancy was likely due to impurities in the natural sample, as evidenced by 
unidentified peaks in the authentic NMR chart.  
The current investigation was concluded with the synthesis of 3, which is a regioisomer of 2. An 
esterification reaction between 18 and 32 with successive deprotection gave alcohol 33, which was then 
subjected to a two-step oxidation to yield the carboxylic acid 34. Finally, deprotection of the MOM 
group on the sugar moiety with aqueous HCl and successive esterification resulted in the synthesis of 
all-methylated rugosin B (3). The NMR spectrum and the optical rotation of synthetic 2 matched those 
of the reported data.23) 
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SCHEME 7. Synthesis of 2 and 3. 
 
 
Conclusions 
An efficient strategy for the synthesis of valoneoyl-containing ellagitannins, which involved a Pd-
catalyzed intramolecular biaryl coupling reaction, Bringmann’s lactone opening reaction, and a two-step 
ester formation with the sugar core, was demonstrated. This process enabled syntheses of the valoneic 
acid derivative (1), and all-methylated versions of isorugosin B (2) and rugosin B (3). Based on these 
results, further syntheses of other natural ellagitannins, including isorugosin B, rugosin B, and oenothein 
B are underway. 
 
Experimental Section 
General Information 
Melting points were measured using Yanagimoto micro melting point hot-plate and are uncorrected. 
Optical rotations were determined on a JASCO P-1020 or -1030 digital polarimeter. IR spectra were 
recoded on a Jasco FTIR-350 spectrophotometer. NMR spectra were taken with Varian Unity INOVA 
AS600 (600 MHz), Varian VXR-500 (500 MHz), Mercury 300 (300 MHz) or JEOL α-400 (400 MHz) 
instrument. Chemical shifts are given in δ parts per million with TMS as an internal standard. Elemental 
analyses were performed with Yanaco MT-5 or Elementar vario MICRO cube analyzer. FABMS was 
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obtained with a VG-70SE or JEOL JMS-AX505HAD instrument using m-nitrobenzyl alcohol as the 
matrix. EIMS was obtained with JEOL JMS-700 or JMS-GCmate II instrument. HPLC was carried out 
using a Shimadzu LC-6A system, Shimadzu SPD-6A UV detector, Daicel CHIRALPACK® AD or 
CHIRALCEL® OD column. Silica gel column chromatography was carried out using wakogel® C-200 
(Wako) or 9385 Kieselgel 60 (Merck). TLC analysis was performed on Kieselgel 60 F254 (Merck) plates. 
Solvents were dried using standard procedure. 
Methyl 2-(3-benzyloxy-5-formyl-2-methoxyphenoxy)-3,4,5-trimethoxybenzoate (21). The mixture 
of 22 (7.50 g, 29.0 mmol), 9 (26.6 g, 87.2 mmol), and Cu (11.1 g, 175 mmol) in DMF (25 mL) was 
heated at 200 °C under Ar. After stirring for 1 h, the reaction mixture was cooled to ambient temperature, 
diluted with EtOAc, and filtrated. The filtrate was poured into H2O (250 mL) and extracted with EtOAc 
(250 mL×3). The combined organic layer was washed with brine, dried over MgSO4, and filtrated. The 
filtrate was evaporated and the resulting residue (31.2 g) was purified by silica gel column 
chromatography (1 : 2 ; EtOAc : hexane) and recrystallization from EtOAc-hexane, providing 21 (10.3 g, 
73%) as pale yellow prisms: mp 108-109.5°C (EtOAc-hexane); IR (KBr) υmax 2950, 2840, 1725, 1700, 
1590, 1490, 1460, 1430, 1415, 1380, 1350, 1330, 1230, 1185, 1125, 1100, 1030, 990, 945, 840, 740, 
700 cm-1; 1H-NMR (300 MHz, CDCl3) δ 3.74 (3H, s, OMe), 3.77 (3H, s, OMe), 3.94 (3H, s, OMe), 3.97 
(3H, s, OMe), 4.10 (3H, s, OMe), 5.22 (2H, s, CH2), 6.65 (1H, d, J = 1.8 Hz, Ar-4’ or 6’-H), 7.20 (1H, d, 
J = 1.8 Hz, Ar-4’ or 6’-H), 7.31-7.51 (6H, m, C6H5, Ar-6-H) 9.67 (1H, s, CHO); 13C-NMR (75 MHz, 
CDCl3) δ 52.3, 56.3, 61.3, 61.3, 61.5, 71.2, 108.3, 108.9, 109.6, 119.3, 127.5, 128.2, 128.7, 131.4, 136.4, 
142.1, 143.9, 147.0, 147.3, 150.5, 153.1, 153.2, 165.0, 190.9; Anal. calculated for C26H26O9 : C, 64.72 ; 
H, 5.43. found : C, 64.78 ; H, 5.21; FAB-mass (positive ion mode) m/z : 482[M]+, 483[M+H]+. 
Methyl 2-(3-hydroxy-5-hydroxymethyl-2-methoxyphenoxy)-3,4,5-trimethoxybenzoate (23). To a 
stirring solution of 21 (9.00 g, 18.7 mmol) in MeOH (200 mL), NaBH4 (1.42 g, 37.5 mmol) was added 
and the resulting mixture was stirred at room temperature under Ar atmosphere. After 30 minute, the 
reaction mixture was warmed to 40°C and stirred. After check of TLC, the reaction mixture was 
quenched with 1N HCl aq. (100 mL) and evaporated to remove most of MeOH. The resulting residue 
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was poured into H2O (50 mL) and extracted with EtOAc (150 mL×3). The combined organic layer was 
washed with sat. NaHCO3 aq. (150 mL) and brine (150 mL), dried over MgSO4, and filtrated. The 
filtrate was evaporated to afford alcohol (11.8 g) as colorless prisms, which was used in the next 
reaction without further purification: mp 118-120°C (EtOAc-hexane); IR (KBr) υmax 3500, 2960, 2360, 
1700, 1600, 1430, 1350, 1240, 1220, 1130, 1100, 740 cm-1; 1H-NMR (300 MHz, CDCl3) δ 3.73 (3H, s, 
OMe), 3.78 (3H, s, OMe), 3.92 (3H, s, OMe), 3.96 (3H, s, OMe), 4.00 (3H, s, OMe), 4.44 (2H, s, 
CH2OH), 5.16 (2H, s, PhCH2O), 6.09 (1H, d, J = 1.8 Hz, Ar-4’ or 6’-H), 6.68 (1H, d, J = 1.8 Hz, Ar-4’ 
or 6’-H), 7.28-7.49 (6H, m, C6H5, Ar-6-H); 13C-NMR (75 MHz, CDCl3) δ 52.3, 56.2, 61.1, 61.3, 61.5, 
65.0, 71.0, 105.8, 106.3, 108.7, 119.4, 127.4, 128.0, 128.6, 136.5, 137.1, 137.6, 142.7, 147.1, 147.2, 
150.1, 152.6, 152.9, 165.5; Anal. calculated for C26H28O9 : C, 64.45 ; H, 5.83. found : C, 64.37 ; H, 5.74. 
found : C, 69.74 ; H, 5.42; FAB-mass (positive ion mode) m/z : 484[M]+, 485[M+H]+. The above 
alcohol was dissoleved in MeOH (100 mL), 10% Pd/C (1.00 g) was added at room temperature. Under 
H2 (1 atm) atmosphere, the mixture was stirred for 2 h, which was filtrated and evaporated. The obtained 
colorless solid (8.16 g) was recrystallized from EtOAc-hexane, providing 23 (6.72 g, 91%) as a colorless 
solid: mp 141-143°C (EtOAc-hexane); IR (KBr) υmax 3480, 3160, 3000, 2960, 1720, 1600, 1460, 1430, 
1410, 1360, 1220, 1080, 1040, 995, 965, 800, 780 cm-1; 1H-NMR (300 MHz, CDCl3) δ 3.73 (3H, s, 
OMe), 3.75 (3H, s, OMe), 3.93 (3H, s, OMe), 3.96 (3H, s, OMe), 4.07 (3H, s, OMe), 4.41 (2H, s, 
CH2OH), 5.95 (1H, s, ArOH, exchange with D2O), 5.98 (1H, d, J = 1.8 Hz, Ar-4’ or 6’-H), 6.60 (1H, d, 
J = 1.8 Hz, Ar-4’ or 6’-H), 7.28 (1H, s, Ar-6-H); 13C-NMR (75 MHz, CDCl3) δ 52.4, 56.3, 61.3, 61.5, 
64.9, 104.4, 107.5, 108.8, 119.5, 134.8, 137.0, 142.2, 147.1, 147.3, 149.7, 150.3, 151.9, 165.4; Anal. 
calculated for C19H22O9 : C, 57.86 ; H, 5.62. found : C, 57.81 ; H, 5.43; FAB-mass (positive ion mode) 
m/z : 394[M]+. 
Methyl 2-(5-tert-butyldimethylsilyloxymethyl-3-hydroxy-2-methoxyphenoxy)-3,4,5-
trimethoxybenzoate (24). To a solution of 23 (4.50 g, 11.4 mmol) in CH2Cl2 (150 mL), TBSCl (3.10 g, 
20.6 mmol), and imidazole (1.40 g, 20.6 mmol) were added at room temperature. After stirring for 10 
min under Ar atomosphere, the mixture was poured into H2O (100 mL) and extracted with CH2Cl2 (100 
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mL×3). The combined organic layer was washed with brine (100 mL), dried over MgSO4, and filtrated. 
The filtrate was evaporated, and the pale yellow residue (11.1 g) was purified by silica gel column 
chromatography (1 : 2 ; EtOAc : hexane), providing 24 (5.49 g, 95%) as a colorless oil: IR (neat) υmax 
3440, 2960, 2860, 2360, 1730, 1720, 1600, 1505, 1495, 1460, 1430, 1415, 1350, 1220, 1120, 1080, 
1040, 990, 840, 780 cm-1; 1H-NMR (300 MHz, CDCl3) δ -0.04 (6H, s, SiMe2), 0.80 (9H, s, SitBu), 3.72 
(3H, s, OMe), 3.74 (3H, s, OMe), 3.92 (3H, s, OMe), 3.95 (3H, s, OMe), 4.07 (3H, s, OMe), 4.48 (2H, s, 
CH2OTBS), 5.85 (1H, s, ArOH, exchange with D2O), 5.96 (1H, d, J = 1.8 Hz, Ar-4’ or 6’-H), 6.54 (1H, 
d, J = 1.8 Hz, Ar-4’ or 6’-H), 7.29 (1H, s, Ar-6-H); 13C-NMR (75 MHz, CDCl3) δ -5.3, 18.3, 25.9, 52.4, 
56.4, 61.3, 61.4, 61.4, 64.4, 103.4, 106.0, 108.8, 119.6, 134.1, 137.5, 142.4, 147.3, 147.4, 149.5, 150.3, 
151.8, 165.4; Anal. calculated for C25H36O9Si : C, 59.03 ; H, 7.13. found : C, 58.73 ; H, 7.09; FAB-mass 
(positive ion mode) m/z : 508[M]+, 509[M+H]+. 
5-tert-Butyldimethylsilyloxymethyl-2-methoxy-3-(2,3,4-trimethoxy-6-methoxycarbonylphenoxy)-
phenyl-2-iodo-3,4,5-trimethoxybenzoate (25). To a solution of 6 (4.38 g, 13.0 mmol) and 24 (5.49 g, 
10.8 mmol) in CH2Cl2 (100 ml), EDC (3.10 g, 16.2 mmol) and DMAP (0.396 g, 3.24 mmol) were added 
at room temperature. After stirring for 3 h under Ar atmosphere, the reaction mixture was poured into 
H2O (200 mL) and then extracted with CH2Cl2 (100 mL×3). The combined organic layer was washed 
with brine (100 mL), dried over MgSO4, and filtrated. The filtrate was evaporated to give the pale 
yellow residue (11.3 g) which was purified by silica gel column chromatography (1 : 2 ; EtOAc : 
hexane), providing 25 (8.93 g, 100%) as a colorless amorphous foam: IR (CHCl3) υmax 3020, 2940, 2860, 
1730, 1590, 1460, 1430, 1340, 1230, 1200, 1170, 1125, 1105, 1080, 1040, 1000, 840, 670. cm-1; 1H-
NMR (500 MHz, CDCl3) δ -0.02 (6H, s, SiMe2), 0.81 (9H, s, SitBu), 3.75 (3H, s, OMe), 3.78 (3H, s, 
OMe), 3.91 (3H, s, OMe), 3.93 (3H, s, OMe), 3.95 (3H, s, OMe), 3.96 (6H, s, OMe), 4.04 (3H, s, OMe), 
4.57 (2H, s, CH2OTBS), 6.39 (1H, d, J = 2.0 Hz, phenyl-6-H), 6.80 (1H, d, J = 2.5 Hz, phenyl-4-H), 
7.31 (1H, s, phenyl-5’-H), 7.52 (1H, s, benzoate-6-H); 13C-NMR (75 MHz, CDCl3) δ -5.3, 18.2, 25.9, 
52.5, 56.4, 56.5, 61.0, 61.2, 61.3, 61.3, 61.5, 63.9, 84.9, 108.9, 109.6, 111.4, 113.0, 119.5, 129.9, 137.1, 
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139.4, 142.3, 144.1, 145.6, 147.2, 147.3, 150.4, 153.0, 153.5, 154.2, 164.6, 165.4; HRMS (FAB, 
positive ion mode) calcurated for C35H46O13SiI [M+H]+ : 829.1753; found : 829.1744 [M+H]+. 
1-tert-Butyldimethylsilyloxymethyl-3-(2,3,4-trimethoxy-6-methoxycarbonylphenoxy)-4,8,9,10-
tetramethoxydibenzo [b,d] pyran-6-one (26). To a stirring solution of 25 (8.47 g, 10.2 mmol) in DMA 
(150 mL), NaOAc (1.68 g, 20.5 mmol), Pd(OAc)2 (572 mg, 2.55 mmol), and PPh3 (1.34 g, 5.11 mmol) 
were added at room temperature. The resulting mixture was heated at 120°C and stirred under Ar 
atmosphere. After 80 min, the reaction mixture was cooled to room temperature, diluted with EtOAc 
(300 mL), and filtrated to remove solid material. The filtrate was poured into H2O (500 mL) and 
extracted with EtOAc (300 mL×3). The combined organic layer was washed with brine (200 mL), dried 
over MgSO4, and filtrated. The filtrate was evaporated and the resulting residue (15.2 g) was purified by 
silica gel column chromatography (1 : 2 ; EtOAc : hexane) and recrystallization from EtOAc-hexane, 
providing 26 (3.77 g, 53%) as colorless needles: mp 171-173°C (EtOAc-hexane); IR (KBr) υmax 2950, 
2850, 1735, 1595, 1480, 1460, 1430, 1340, 1220, 1120, 1080, 1000, 840, 780 cm-1; 1H-NMR (500 MHz, 
CDCl3) δ -0.18 (6H, s, SiMe2), 0.70 (9H, s, SitBu), 3.49 (3H, s, OMe), 3.72 (3H, s, OMe), 3.80 (3H, s, 
OMe), 3.94 (3H, s, OMe), 3.98 (3H, s, OMe), 4.00 (3H, s, OMe), 4.05 (3H, s, OMe), 4.16 (3H, s, OMe), 
4.60 (2H, s, CH2OTBS), 6.77 (1H, s, Ar-2-H), 7.33 (1H, s, Ar-5’-H), 7.69 (1H, s, Ar-7-H); 13C-NMR 
(75 MHz, CDCl3) δ -5.5, 18.2, 25.8, 52.3, 56.4, 56.5, 61.3, 61.4, 61.5, 61.5, 61.9, 64.0, 108.0, 109.0, 
109.6, 110.2, 118.1, 119.4, 123.3, 134.7, 135.0, 142.3, 144.2, 147.2, 147.4, 148.4, 149.5, 150.5, 152.3, 
153.1, 161.0, 165.2; Anal. calculated for C35H44O13Si : C, 59.98 ; H, 6.33. found : C, 59.74 ; H, 6.31; 
FAB-mass (positive ion mode) m/z : 700[M]+, 701[M+H]+. 
(S)-6-tert-Butyldimethylsilyloxymethyl-2-hydroxy-6’-hydroxymethyl-2’,3,3’4’-tetramethoxy-4-
(2,3,4-trimethoxy-6-methoxycarbonylphenoxy)-1,1’-biphenyl (27). To a solution of (S)-5,5-
Diphenyl-2-methyl-3,4-propano-1,3,2-oxazaborolidine (2.37 g, 8.55 mmol) in THF (50 mL), 1.06 M 
BH3·THF in THF solution (10.8 mL, 11.4 mmol) was added at 0°C and the mixture was warmed to 
room temperature. After stirring for 30 minute under N2 atmosphere, a solution of 26 (2.00 g, 2.85 
mmol) in THF (120 mL) was dropwise added over 1 h at -40°C and the resulting mixture was stirred for 
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15 h at the same temperature. The reaction mixture was then quenched with H2O (50 mL), evaporated to 
remove most of THF, and poured into H2O (50 mL). The aqueous solution was acidified with 10% HCl 
aq. (0.5 mL) and extracted with Et2O (120 mL×3). The combined organic layer was washed with brine 
(100 mL), dried over MgSO4 and filtrated. The filtrate was evaporated and the pale yellow residue (5.08 
g) was purified by silica gel column chromatography (2 : 1 ; EtOAc : hexane), providing 27 (1.93 g, 
96%, 98% ee) as a colorless solid: mp 77.9-80.9°C (Et2O-hexane); [α]D18 = -2.4° (c = 0.54, CHCl3); IR 
(CHCl3) υmax 3680, 3000, 2940, 2860, 1710, 1595, 1485, 1460, 1435, 1420, 1340, 1235, 1120, 1090, 
1000, 840, 670 cm-1; 1H-NMR (400 MHz, CDCl3) δ -0.19 (3H, s, SiMe), -0.19 (3H, s, SiMe), 0.68 (9H, 
s, SitBu), 3.56 (3H, s, OMe), 3.74 (3H, s, OMe), 3.76 (3H, s, OMe), 3.89 (3H, s, OMe), 3.92 (3H, s, 
OMe), 3.93 (3H, s, OMe), 3.96 (3H, s, OMe), 4.07 (1H, d, B of AB, J = 13.2 Hz, CHAHB), 4.13 (3H, s, 
OMe), 4.21 (1H, d, A of AB, J = 13.2 Hz, CHAHB), 4.24 (2H, s, CH2), 6.26 (1H, s, 5-H), 6.91 (1H, s, 5’-
H), 7.30 (1H, s, Phenoxy-5-H); 13C-NMR (75 MHz, CDCl3) δ -5.6, -5.5, 18.2, 25.8, 52.3, 56.0, 56.4, 
60.9, 61.1, 61.3, 61.3, 61.5, 62.8, 63.8, 105.3, 108.6, 108.9, 114.1, 119.6, 120.6, 134.3, 135.9, 136.1, 
142.0, 142.5, 146.7, 147.3, 147.4, 150.4, 151.3, 151.6, 153.4, 165.5; Anal.calculated for C35H48O13Si : C, 
59.64 ; H, 6.86. found : C, 59.64 ; H, 6.98; FAB-Mass (positive ion mode) m/z : 704 [M]+; HPLC 
conditions : Daicel CHIRALPACK® AD, iPrOH/hexane 1 : 15, 1.0 mLmin-1, 254 nm, Rt (minor) = 24.7 
min, Rt (major) = 29.4 min. 
(S)-6-tert-Butyldimethylsilyloxymethyl-6’-hydroxymethyl-2,2’,3,3’4’-pentamethoxy-4-(2,3,4-
trimethoxy-6-methoxycarbonylphenoxy)-1,1’-biphenyl (28). To a solution of 27 (1.86 g, 2.64 mmol) 
in THF (60 mL), MeI (0.2 mL, 3.21 mmol) and tBuOK (0.360 g, 3.21 mmol) were added at 0°C. The 
resulting mixture was warmed to room temperature and stirred for 48 h under N2 atmosphere. The 
reaction mixture was poured into H2O (100 mL), and extracted with Et2O (150 mL×3). The combined 
organic layer was washed with brine (50 mL), dried over MgSO4, and filtrated. The filtrate was 
evaporated and the resulting residue (1.97 g) was purified by silica gel column chromatography (1 : 1 ; 
EtOAc : hexane), providing 28 (1.52 g, 80%, 97% ee) as a pale yellow amorphous: [α]D18 = +17.6° (c = 
0.53, CHCl3); IR (CHCl3) υmax 3020, 2940, 2860, 1710, 1595, 1480, 1460, 1430, 1415, 1395, 1350, 
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1320, 1235, 1120, 1090, 1000, 840, 670 cm-1; 1H-NMR (500 MHz, CDCl3) δ -0.19 (3H, s, SiMe), -0.18 
(3H, s, SiMe), 0.68 (9H, s, SitBu), 3.66 (3H, s, OMe), 3.73 (3H, s, OMe), 3.74 (3H, s, OMe), 3.78 (3H, s, 
OMe), 3.86 (3H, s, OMe), 3.92 (3H, s, OMe), 3.93 (3H, s, OMe), 3.96 (3H, s, OMe), 4.03 (1H, d, B of 
AB, J = 13.5 Hz, CHAHBOTBS), 4.04 (3H, s, OMe), 4.15 (2H, s, ArCH2OH), 4.24 (1H, d, A of AB, J = 
13.5 Hz, CHAHBOTBS), 6.48 (1H, s, Ar-5-H), 6.87 (1H, s, Ar-5’-H), 7.30 (1H, s, phenoxy-5-H); 13C-
NMR (75 MHz, CDCl3) δ -5.5, -5.5, 18.2, 25.8, 52.3, 56.0, 56.4, 60.7, 60.9, 61.1, 61.3, 61.3, 62.6, 63.9, 
108.4, 108.8, 108.9, 119.5, 121.0, 121.1, 135.7, 135.8, 140.7, 141.5, 143.0, 147.2, 147.4, 150.2, 151.0, 
151.2, 152.7, 153.4, 165.6; HRMS (EI) calculated for C36H50O13Si [M]+ : 718.3021; found : 718.2998 
[M]+; HPLC conditions : Daicel CHIRALCEL® OD, iPrOH/hexane 1 : 15, 0.5 mLmin-1, 254 nm, Rt 
(minor) = 35.6 min, Rt (major) = 44.3 min. 
(S)-6’-tert-Butyldimethylsilyloxymethyl-2,2’,3,3’4-pentamethoxy-4’-(2,3,4-trimethoxy-6-
methoxycarbonylphenoxy)-1,1’-biphenyl-6-carboxylic acid (18). To a stirring suspension of PDC 
(1.46 g, 3.88 mmol) in CH2Cl2 (10 mL), a solution of 28 (1.40 g, 1.95 mmol) in CH2Cl2 (30 mL) was 
added at 0°C. After stirring for 25 h at room temperature, the reaction mixture was filtrated with celite 
and the filtrate was evaporated. The resulting residue (1.68 g) was purified by silica gel column 
chromatography (1 : 2 ; EtOAc : hexane), providing aldehyde (1.16 g, 83%, 96% ee) as a colorless 
amorphous: [α]D15 = +3.5° (c = 0.46, CHCl3); IR (CHCl3) υmax 3010, 2940, 2860, 1710, 1680, 1590, 
1480, 1460, 1430, 1415, 1350, 1320, 1230, 1120, 1090, 1000, 840, 670 cm-1; 1H-NMR (500 MHz, 
CDCl3) δ -0.213 (3H, s, SiMe), -0.209 (3H, s, SiMe), 0.67 (9H, s, SitBu), 3.62 (3H, s, OMe), 3.73 (3H, s, 
OMe), 3.75 (3H, s, OMe), 3.79 (3H, s, OMe), 3.92 (3H, s, OMe), 3.96 (3H, s, OMe), 3.97 (3H, s, OMe), 
3.98 (3H, s, OMe), 4.04 (3H, s, OMe), 4.07 (1H, d, B of AB, J = 14.0 Hz, CHAHBOTBS), 4.21 (1H, d, A 
of AB, J = 14.0 Hz, CHAHBOTBS), 6.51 (1H, s, Ar-5-H), 7.30 (1H, s, ArH), 7.35 (1H, s, ArH), 9.55 (1H, 
s, CHO); 13C-NMR (75 MHz, CDCl3) δ -5.6, -5.6, 18.1, 25.8, 52.3, 56.2, 56.4, 60.8, 61.2, 61.3, 61.4, 
62.5, 105.1, 107.8, 108.9, 117.2, 119.5, 128.2, 129.8, 136.2, 140.3, 142.8, 147.3, 147.4, 147.8, 150.3, 
151.3, 151.7, 153.4, 153.4, 165.5, 191.3; Anal.calculated for C36H48O13Si : C, 60.32 ; H, 6.75. found : C, 
60.22 ; H, 7.05; FAB-mass (positive ion mode) m/z : 716 [M]+, 717 [M+H]+; HPLC conditions : Daicel 
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CHIRALPACK® AD, iPrOH/hexane 1 : 30, 0.5 mLmin-1, 254 nm, Rt (minor) = 18.6 min, Rt (major) = 21.5 
min. The above aldehyde (1.10 g, 1.50 mmol) was dissolved in THF (10 mL) and tBuOH (10 mL), and 
2-methyl-2-butene (1.30 mL, 12.2 mmol) was added. The mixture was stirred at room temperature, and 
a solution of 80% NaClO2 (0.520 g, 4.60 mmol) and NaH2PO4･2H2O (1.20 g, 7.69 mmol) in H2O (10 
mL) was dropwise added at room temperature. After stirring for 3 h, the reaction mixture was poured 
into H2O (10 mL) and extracted with Et2O (50 mL×3). The combined organic layer was washed with 
brine (30 mL), dried over MgSO4, and filtrated. The filtrate was evaporated and the resulting residue 
(1.54 g) was purified by silica gel column chromatography (1 : 1 ; EtOAc : hexane), providing 18 (1.07 
g, 95%) as a colorless amorphous: [α]D15 = +16.0° (c = 0.57, CHCl3); IR (CHCl3) υmax 3010, 2940, 2860, 
1720, 1595, 1480, 1460, 1430, 1420, 1400, 1350, 1320, 1230, 1120, 1085, 1035, 1000, 840, 670 cm-1; 
1H-NMR (500 MHz, CDCl3) δ -0.17 (3H, s, SiMe), -0.14 (3H, s, SiMe), 0.68 (9H, s, SitBu), 3.59 (3H, s, 
OMe), 3.75 (3H, s, OMe), 3.75 (3H, s, OMe), 3.77 (3H, s, OMe), 3.93 (3H, s, OMe), 3.93 (3H, s, OMe), 
3.94 (3H, s, OMe), 3.96 (3H, s, OMe), 4.00 (3H, s, OMe), 4.11 (1H, d, B of AB, J = 11.5 Hz, 
CHAHBOTBS), 4.33 (1H, d, A of AB, J = 11.5 Hz, CHAHBOTBS), 6.33 (1H, s, Ar-5’-H), 7.21 (1H, s, 
ArH), 7.29 (1H, s, ArH); 13C-NMR (75 MHz, CDCl3) δ -5.7, -5.6, 18.2, 25.8, 52.3, 56.2, 56.3, 60.7, 
61.0, 61.0, 61.0, 61.2, 61.3, 63.8, 108.6, 108.8, 109.5, 119.6, 121.8, 124.2, 127.0, 134.0, 141.0, 143.0, 
145.9, 147.3, 147.4, 150.2, 151.3, 151.4, 152.7, 152.8, 165.8, 170.6; HRMS (EI) calculated for 
C36H48O14Si [M]+ : 732.2813; found : 732.2839 [M]+. 
Methyl 4-O-tert-butyldimethylsilyl-6-O-[(S)-2-{6-hydroxymethyl-2,3-dimethoxy-4-(2,3,4-
trimethoxy-6-methoxycarbonylphenoxy)-phenyl}-3,4,5-trimethoxybenzoyl]-2,3-di-O-(3,4,5-
trimethoxybenzoyl)-α-D-glucopyranoside (30). To a solution of 18 (742 mg, 1.01 mmol) and 29 (845 
mg, 1.21 mmol) in CH2Cl2 (12 ml), EDC (350 mg, 1.83 mmol) and DMAP (50.0 mg, 0.410 mmol) were 
added at room temperature. After stirring for 24 h under N2 atmosphere, the reaction mixture was 
poured into H2O (25 mL) and then extracted with CH2Cl2 (25 mL×3). The combined organic layer was 
washed with brine (25 mL), dried over MgSO4, and filtrated. The filtrate was evaporated and the 
colorless residue (1.67 g) was subjected to silica gel column chromatography (1 : 1 ; EtOAc : hexane), 
 17 
providing a mixture (1.47 g) of ester product and 29 as a colorless amorphous foam. The obtained 
mixture was directly dissolved in THF (7 mL) and H2O (14 mL), and then AcOH (42 mL) was added to 
the solution which was stirred at room temperature. After 9 h, the reaction mixture was extracted with 
Et2O (100 mL×3) and the combined organic layer was washed with sat. NaHCO3 aq. (80 mL×3), H2O 
(80 mL) and brine (80 mL). The organic solution was dried over MgSO4, filtrated, and evaporated. The 
resulting residue (1.37 g) was purified by silica gel column chromatography (2 : 1 ; EtOAc : hexane), 
providing colorless amorphous 30 (1.05 g, 80%) as a single diastereoisomer: [α]D17 = +88.5° (c = 0.57, 
CHCl3); IR (CHCl3) υmax 2940, 2360, 1720, 1590, 1460, 1420, 1340, 1230, 1130, 1085, 840, 670 cm-1; 
1H-NMR (400 MHz, CDCl3) δ -0.09, (3H, s, SiMe), 0.08 (3H, s, SiMe), 0.77 (9H, s, SitBu), 2.64 (1H, t, 
J = 6.0 Hz, CH2OH, exchange with D2O), 3.39 (3H, s, OMe), 3.58 (3H, s, OMe), 3.754 (3H, s, OMe), 
3.75 (3H, s, OMe), 3.76 (6H, s, OMe), 3.83 (9H, s, OMe), 3.85 (6H, s, OMe), 3.85 (3H, s, OMe), 3.92 
(3H, s, OMe), 3.93 (3H, s, OMe), 3.94 (3H, s, OMe), 3.95 (3H, s, OMe), 3.99-4.14 (3H, m), 4.00 (3H, s, 
OMe), 4.64 (1H, dd, A of ABX, J = 1.2, 11.6 Hz, 6-H), 4.90 (1H, dd, J = 3.6, 10.0 Hz, 2-H), 5.08 (1H, d, 
J = 3.6 Hz, 1-H), 5.82 (1H, dd, J = 8.4, 10.0 Hz, 3-H), 6.48 (1H, s, Valoneoyl-H), 7.17 (2H, s, Galloyl-
H), 7.18 (2H, s, Galloyl-H), 7.264 (1H, s, Valoneoyl-H), 7.35 (1H, s, Valoneoyl-H); 13C-NMR (100 
MHz, CDCl3) δ -4.5, -4.0, 17.9, 25.6, 52.2, 55.4, 56.1, 56.2, 56.3, 56.3, 60.8, 60.9, 60.9, 60.9, 61.0, 61.1, 
61.2, 61.3, 63.5, 63.9, 69.9, 70.1, 72.9, 73.5, 96.7, 107.0, 107.2, 108.8, 109.3, 110.9, 119.5, 123.3, 124.1, 
124.9, 125.9, 126.1, 134.9, 141.7, 142.6, 142.6, 143.1, 146.2, 147.3, 147.4, 150.2, 151.1, 152.0, 152.6, 
152.9, 153.0, 153.1, 165.8, 165.8, 165.9, 166.6; HRMS (FAB, positive ion mode) calculated for 
C63H81O27Si [M+H]+ : 1297.4735; found : 1297.4753 [M+H]+. 
Methyl 4-O-tert-butyldimethylsilyl-6-O-[(S)-2-{6-carboxy-2,3-dimethoxy-4-(2,3,4-trimethoxy-6-
methoxycarbonylphenoxy)-phenyl}-3,4,5-trimethoxybenzoyl]-2,3-di-O-(3,4,5-trimethoxybenzoyl)-
α-D-glucopyranoside (31). To a solution of 30 (873 mg, 0.673 mmol) in CH2Cl2 (25 mL), Dess-Martin 
periodinane (570 mg, 1.34 mmol) was added at room temperature. After the reaction mixture was stirred 
for 3 h, it was quenched with 10% Na2S2O3 aq. (10 mL), poured into H2O (40 mL) and extracted with 
CH2Cl2 (25 mL×3). The combined organic layer was washed with brine (25 mL), dried over MgSO4 and 
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filtrated. The filtrate was evaporated and the colorless residue (978 mg) was purified by silica gel 
column chromatography (2 : 1 ; EtOAc : hexane), providing aldehyde (865 mg, 99%) as a colorless 
amorphous: [α]D18 = +52.9° (c = 0.66, CHCl3); IR (CHCl3) υmax 3020, 2940, 1720, 1685, 1590, 1460, 
1420, 1340, 1230, 1175, 1130, 1090, 1035, 1000, 840, 670 cm-1; 1H-NMR (400 MHz, CDCl3) δ -0.11, 
(3H, s, SiMe), 0.02 (3H, s, SiMe), 0.75 (9H, s, SitBu), 3.37 (3H, s, OMe), 3.58 (3H, s, OMe), 3.74 (6H, s, 
OMe), 3.75 (3H, s, OMe), 3.827 (6H, s, OMe), 3.833 (3H, s, OMe), 3.85 (9H, s, OMe), 3.93 (3H, s, 
OMe), 3.948 (3H, s, OMe), 3.954 (3H, s, OMe), 3.96 (3H, s, OMe), 4.12 (3H, s, OMe), 4.58 (1H, dd, A 
of ABX, J = 1.6, 11.6 Hz, 6-H), 4.92 (1H, dd, J = 3.6, 10.4 Hz, 2-H), 5.11 (1H, d, J = 3.6 Hz, 1-H), 5.82 
(1H, dd, J = 8.4, 10.4 Hz, 3-H), 6.93 (1H, s, Valoneoyl-H), 7.17 (2H, s, Galloyl-H), 7.19 (2H, s, Galloyl-
H), 7.29 (1H, s, Valoneoyl-H), 7.46 (1H, s, Valoneoyl-H), 9.46 (1H, s, CHO), glu-4-, 5-, and 6’-H 
overlapped with OMe signals; 13C-NMR (100 MHz, CDCl3) δ -4.5, -4.0, 17.9, 25.6, 52.3, 55.4, 56.2, 
56.3, 56.3, 56.4, 60.7, 61.0, 61.0, 61.0, 61.2, 61.2, 61.2, 61.4, 63.6, 70.0, 70.1, 73.0, 73.6, 96.7, 107.0, 
107.2, 108.5, 109.1, 109.5, 119.4, 123.4, 124.2, 124.9, 126.0, 129.4, 129.6, 142.6, 142.6, 146.1, 147.2, 
147.5, 147.5, 150.6, 151.5, 152.4, 153.1, 165.3, 165.5, 165.8, 165.9, 190.5.; FAB-mass (positive ion 
mode) m/z : 1295 [M+H]+. To a solution of the above aldehyde (256 mg, 0.198 mmol) in THF (4 mL) 
and tBuOH (4 mL), 2-methyl-2-butene (0.166 mL, 1.58 mmol) was added at room temperature. A 
solution of 80% NaClO2 (67.2 mg, 0.594 mmol) and NaH2PO4･2H2O (155 mg, 0.994 mmol) in H2O (2 
mL) was dropwise added to the mixture. After stirring for 12 h, the reaction mixture was acidified with 
10% HCl aq. (1 mL) and extracted with Et2O (20 mL×3). The combined organic layer was washed with 
brine (10 mL), dried over MgSO4, and filtrated. The filtrate was evaporated and the yellow residue (283 
mg) was purified by silica gel column chromatography (1 : 14 : 28 ; EtOH : EtOAc : CHCl3), providing 
31 (193 mg, 74%) as a colorless amorphous: [α]D19 = +65.1° (c = 0.80, CHCl3); IR (CHCl3) υmax 3020, 
2940, 2360, 1720, 1590, 1460, 1420, 1340, 1230, 1130, 1085, 675, 665 cm-1; 1H-NMR (400 MHz, 
CDCl3) δ -0.10, (3H, s, SiMe), 0.06 (3H, s, SiMe), 0.76 (9H, s, SitBu), 3.38 (3H, s, OMe), 3.57 (3H, s, 
OMe), 3.68 (3H, s, OMe), 3.74 (3H, s, OMe), 3.76 (3H, s, OMe), 3.83 (6H, s, OMe), 3.84 (3H, s, OMe), 
3.858 (6H, s, OMe), 3.862 (3H, s, OMe), 3.88 (3H, s, OMe), 3.93 (6H, s, OMe), 3.95 (3H, s, OMe), 4.06 
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(3H, s, OMe), 4.10 (1H, dd, B of ABX, J = 5.2, 11.6 Hz, 6-H), 4.63 (1H, dd, A of ABX, J = 1.2, 11.6 Hz, 
6-H), 4.91 (1H, dd, J = 3.6, 10.4 Hz, 2-H), 5.09 (1H, d, J = 3.6 Hz, 1-H), 5.82 (1H, dd, J = 8.4, 10.4 Hz, 
3-H), 6.98 (1H, s, Valoneoyl-H), 7.17 (2H, s, Galloyl-H), 7.19 (2H, s, Galloyl-H), 7.27 (1H, s, 
Valoneoyl-H), 7.36 (1H, s, Valoneoyl-H), glu-4- and 5-H overlapped with OMe signals; 13C-NMR (100 
MHz, CDCl3) δ -4.5, -4.0, 18.0, 25.6, 52.3, 55.3, 55.9, 56.2, 56.3, 56.3, 60.6, 60.8, 60.9, 61.0, 61.0, 61.0, 
61.2, 61.3, 63.4, 70.0, 70.2, 73.0, 73.6, 96.7, 107.1, 107.2, 108.9, 108.9, 112.7, 119.4, 124.2, 124.5, 
124.6, 125.0, 127.1, 127.1, 142.6, 142.6, 142.7, 146.0, 146.2, 147.2, 147.4, 150.4, 151.5, 151.7, 152.0, 
152.3, 153.1, 165.7, 165.8, 165.9, 166.0, 170.1; HRMS (FAB, negative ion mode) calculated for 
C63H77O28Si [M-H]- : 1309.4371; found : 1309.4405 [M-H]-. 
All-methylated isorugosin B (Hexadecamethyl derivative of isorugosin B) (2). To a solution of 31 
(55.6 mg, 42.4 μmol) in THF (4 mL), TBAF (85.0 μL, 85.0 μmol) was added at room temperature. After 
stirring for 30 min under N2 atmosphere, the reaction mixture was poured into H2O (10 mL), acidified 
with 10% HCl aq. (1 mL) and extracted with Et2O (15 mL×3). The combined organic layer was washed 
with brine (10 mL), dried over MgSO4, and filtrated. The filtrate was evaporated to afford desilylated 
product (41.1 mg) as a colorless amorphous, which was used in the next reaction without further 
purification. The obtained material was dissolved in CH2Cl2 (42 ml), and then EDC (81.3 mg, 424 μmol) 
and DMAP (25.9 mg, 212 μmol) were added to the solution at room temperature. The reaction mixture 
was stirred for 42 h under N2 atmosphere, it was poured into H2O (40 mL) and extracted with Et2O (40 
mL×3). The combined organic layer was washed with brine (40 mL), dried over MgSO4, and filtrated. 
The filtrate was evaporated and the resulting residue (87.3 mg) was purified by silica gel column 
chromatography (1 : 7 ; EtOAc : CH2Cl2), providing all-methylated isorugosin B (2) (15.8 mg, 32%) as 
a colorless amorphous: [α]D25 = +28.0° (c = 1.52, acetone); 1H-NMR (400 MHz, acetone-d6) δ 3.44 (3H, 
s, OMe), 3.64 (3H, s, OMe), 3.66 (3H, s, OMe), 3.69 (3H, s, OMe), 3.70 (3H, s, OMe), 3.74 (3H, s, 
OMe), 3.75 (6H, s, OMe), 3.76 (3H, s, OMe), 3.85 (6H, s, OMe), 3.89 (3H, s, OMe), 3.90 (3H, s, OMe), 
3.94 (3H, s, OMe), 3.95 (1H, dd, B of ABX, J = 1.2, 13.2 Hz, 6-H), 3.98 (3H, s, OMe), 4.00 (3H, s, 
OMe), 4.44 (1H, ddd, J = 1.2, 6.4, 10.0 Hz, 5-H), 5.15 (1H, dd, J = 4.0, 10.0 Hz, 2-H), 5.17 (1H, t, J = 
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10.0 Hz, 4-H), 5.25 (1H, dd, A of ABX, J = 6.4, 13.2 Hz, 6-H), 5.26 (1H, d, J = 4.0 Hz, 1-H), 5.67 (1H, 
t, J = 10.0 Hz, 3-H), 6.34 (1H, s, Valoneoyl-H), 6.98 (1H, s, Valoneoyl-H), 7.13 (2H, s, Galloyl-H), 7.23 
(2H, s, Galloyl-H), 7.29 (1H, s, Valoneoyl-H); 13C-NMR (100 MHz, acetone-d6) δ 52.4, 55.9, 56.4, 56.5, 
56.5, 56.8, 60.6, 60.7, 60.9, 61.1, 61.1, 61.2, 61.3, 61.6, 64.0, 67.5, 71.0, 72.2, 73.6, 98.4, 107.0, 108.0, 
108.1, 109.1, 109.7, 120.5, 123.0, 124.1, 125.0, 125.1, 128.9, 129.9, 142.6, 143.8, 144.0, 145.1, 145.2, 
148.0, 148.2, 151.7, 153.5, 153.6, 153.9, 154.2, 154.3, 154.3, 165.8, 165.9, 166.3, 167.6, 168.2; HRMS 
(FAB, negative ion mode) calculated for C56H59O27 [M-CH3]- : 1163.3244; found : 1163.3221 [M-CH3]-. 
Methyl 4-O-[(S)-2{6-hydroxymethyl-2,3-dimethoxy-4-(2,3,4-trimethoxy-6-
methoxycarbonylphenoxy)-phenyl}-3,4,5-trimethoxybenzoyl]-6-O-methoxymethyl-2,3-di-O-(3,4,5-
trimethoxybenzoyl)-α-D-glucopyranoside (33). To a solution of 18 (983 mg, 1.34 mmol) and 32 (1,01 
g, 1.61 mmol) in CH2Cl2 (20 ml), EDC (462 mg, 2.41 mmol) and DMAP (65.5 mg, 0.536 mmol) were 
added at room temperature. After stirring for 24 h under N2 atmosphere, the reaction mixture was 
poured into H2O (100 mL) and then extracted with CH2Cl2 (50 mL×3). The combined organic layer was 
washed with brine (50 mL), dried over MgSO4, and filtrated. The filtrate was evaporated and the pale 
yellow residue (2.01 g) was purified by silica gel column chromatography (1 : 1 ; EtOAc : hexane), 
providing ester (1.16 g, 64%) as a colorless amorphous: [α]D25 = -1.0° (c = 0.63, CHCl3); IR (CHCl3) 
υmax 3030, 3010, 2940, 2840, 1725, 1590, 1505, 1460, 1420, 1340, 1235, 1175, 1130, 1085, 1035, 1000, 
920, 860, 670 cm-1; 1H-NMR (400 MHz, CDCl3) δ -0.19, (3H, s, SiMe), -0.10 (3H, s, SiMe), 0.68 (9H, s, 
SitBu), 3.09 (1H, dd, B of ABX, J = 3.2, 11.6 Hz, 6-H), 3.29 (3H, s, OMe), 3.39 (3H, s, OMe), 3.51 (3H, 
s, OMe), 3.564 (3H, s, OMe), 3.572 (1H, dd, A of ABX, J = 2.0, 11.6 Hz, 6-H), 3.68 (3H, s, OMe), 3.73 
(3H, s, OMe), 3.80 (3H, s, OMe), 3.84 (3H, s, OMe), 3.85 (3H, s, OMe), 3.86 (12H, s, OMe), 3.88 (3H, 
s, OMe), 3.91 (3H, s, OMe), 3.94 (3H, s, OMe), 4.01 (3H, s, OMe), 4.06 (1H, d, B of AB, J = 14.0 Hz, 
CHAHB), 4.19 (1H, d, A of AB, J = 14.0 Hz, CHAHB), 4.54 (1H, d, B of AB, J = 6.8 Hz, CHAHB), 4.60 
(1H, d, A of AB, J = 6.8 Hz, CHAHB), 5.03 (1H, dd, J = 3.6, 10.0 Hz, 2-H), 5.20 (1H, d, J = 3.6 Hz, 1-
H), 5.54 (1H, t, J = 10.0 Hz, 3 or 4-H), 5.77 (1H, t, J = 10.0 Hz, 3 or 4-H), 6.50 (1H, s, Valoneoyl-H), 
6.97 (1H, s, Valoneoyl-H), 7.16 (2H, s, Galloyl-H), 7.23 (2H, s, Galloyl-H), 7.28 (1H, s, Valoneoyl-H), 
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glu-5-H overlapped with OMe signals; 13C-NMR (100 MHz, CDCl3) δ -5.7, 18.0, 25.7, 52.2, 55.4, 55.6, 
55.7, 56.2, 56.3, 56.3, 60.5, 60.7, 60.9, 61.0, 61.0, 61.0, 61.2, 61.4, 62.1, 64.9, 68.4, 68.4, 71.5, 72.7, 
97.0, 97.1, 107.0, 107.0, 107.2, 108.9, 109.3, 119.7, 121.1, 124.3, 124.5, 124.5, 125.6, 136.0, 140.1, 
142.5, 142.6, 143.2, 146.0, 147.4, 147.5, 150.3, 151.0, 151.6, 152.5, 152.9, 153.1, 153.1, 165.4, 165.6, 
165.7, 165.8; HRMS (FAB, positive ion mode) calculated for C65H85O28Si [M+H]+ : 1341.4997; found : 
1341.5002 [M+H]+. To a solution of the above ester (1.00 g, 0.745 mmol) in THF (10 mL) and H2O (20 
mL), AcOH (60 mL) was added and stirred at room temperature. After 8 h, the reaction mixture was 
quenched with sat. NaHCO3 aq. (300 mL) and extracted with Et2O (250 mL×3). The combined organic 
layer was washed with sat. NaHCO3 aq. (150 mL×3), H2O (200 mL) and brine (200 mL) and then the 
resulting organic solution was dried over MgSO4, filtrated, and evaporated. The yellow residue (941 mg) 
was purified by silica gel column chromatography (2 : 1 ; EtOAc : hexane), providing colorless 
amorphous 33 (862 mg, 94%) as a single diastereoisomer: [α]D25 = +9.9° (c = 0.60, CHCl3); IR (CHCl3) 
υmax 3520, 3030, 3010, 2940, 2840, 1720, 1590, 1505, 1460, 1420, 1340, 1230, 1175, 1130, 1085, 1035, 
1000, 920, 865, 670 cm-1; 1H-NMR (400 MHz, CDCl3) δ 2.85 (1H, t, J = 6.4 Hz, CH2OH), 3.28 (3H, s, 
OMe), 3.45 (3H, s, OMe), 3.51 (1H, dd, B of ABX, J = 4.0, 11.6 Hz, 6-H), 3.54 (3H, s, OMe), 3.55 (3H, 
s, OMe), 3.64 (1H, dd, A of ABX, J = 2.4, 11.6 Hz, 6-H), 3.75 (3H, s, OMe), 3.82 (9H, s, OMe), 3.84 
(3H, s, OMe), 3.847 (6H, s, OMe), 3.854 (6H, s, OMe), 3.89 (3H, s, OMe), 3.93 (3H, s, OMe), 3.96 (3H, 
s, OMe), 4.01 (3H, s, OMe), 4.55 (1H, d, B of AB, J = 6.8 Hz, OCHAHBOMe), 4.61 (1H, d, A of AB, J 
= 6.8 Hz, OCHAHBOMe), 5.07 (1H, dd, J = 3.2, 10.0 Hz, 2-H), 5.24 (1H, d, J = 3.2 Hz, 1-H), 5.44 (1H, t, 
J = 10.0 Hz, 3 or 4-H), 5.79 (1H, t, J = 10.0 Hz, 3 or 4-H), 6.49 (1H, s, Valoneoyl-H), 7.11 (2H, s, 
Galloyl-H), 7.19 (2H, s, Galloyl-H), 7.23 (1H, s, Valoneoyl-H), 7.27 (1H, s, Valoneoyl-H), glu-5-H and 
CH2OH overlapped with OMe signals; 13C-NMR (100 MHz, CDCl3) δ 52.1, 55.6, 55.6, 56.0, 56.2, 56.2, 
56.3,60.4, 60.6, 60.9, 60.9, 61.0, 61.2, 61.4, 63.0, 65.4, 68.5, 68.6, 71.1, 72.5, 96.8, 97.0, 107.0, 107.2, 
108.8, 108.9, 109.9, 119.6, 123.0, 124.0, 124.0, 124.7, 125.3, 134.6, 141.0, 142.7, 142.8, 143.0, 146.2, 
147.3, 147.5, 150.2, 151.3, 151.6, 152.5, 152.8, 153.1, 165.2, 165.6, 165.8, 166.1; HRMS (FAB, 
positive ion mode) calculated for C59H71O28 [M+H]+ : 1227.4132; found : 1227.4144 [M+H]+. 
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Methyl 4-O-[(S)-2-{6-carboxy-2,3-dimethoxy-4-(2,3,4-trimethoxy-6-methoxycarbonylphenoxy)-
phenyl}-3,4,5-trimethoxybenzoyl]-6-O-methoxymethyl-2,3-di-O-(3,4,5-trimethoxybenzoyl)-α-D-
glucopyranoside (34). To a stirring suspension of PDC (918 mg, 2.44 mmol) in CH2Cl2 (50 mL), a 
solution of 33 (749 mg, 0.610 mmol) in CH2Cl2 (100 mL) was added at 0°C. After stirring for 21 h at 
room temperature, the reaction mixture was filtrated with celite and the filtrate was evaporated. The 
resulting residue (778 mg) was purified by silica gel column chromatography (2 : 1 ; EtOAc : hexane), 
providing aldehyde (731 mg, 98%) as a colorless amorphous: [α]D25 = +24.4° (c = 0.59, CHCl3); IR 
(CHCl3) υmax 3030, 3010, 2940, 2840, 1730, 1690, 1590, 1505, 1460, 1420, 1340, 1230, 1175, 1130, 
1090, 1035, 1000, 920, 860, 670 cm-1; 1H-NMR (400 MHz, CDCl3) δ 3.21 (1H, dd, B of ABX, J = 4.0, 
11.6 Hz, 6-H), 3.27 (3H, s, OMe), 3.42 (3H, s, OMe), 3.50 (3H, s, OMe), 3.54 (3H, s, OMe), 3.56 (1H, 
dd, A of ABX, J = 2.4, 11.6 Hz, 6-H), 3.75 (3H, s, OMe), 3.78 (3H, s, OMe), 3.81 (3H, s, OMe), 3.83 
(6H, s, OMe), 3.84 (3H, s, OMe), 3.85 (9H, s, OMe), 3.90 (3H, s, OMe), 3.94 (3H, s, OMe), 3.97(3H, s, 
OMe), 4.10 (3H, s, OMe), 4.48 (1H, d, B of AB, J = 6.8 Hz, OCHAHBOMe), 4.56 (1H, d, A of AB, J = 
6.8 Hz, OCHAHBOMe), 5.07 (1H, dd, J = 3.6, 10.0 Hz, 2-H), 5.20 (1H, d, J = 3.6 Hz, 1-H), 5.44 (1H, t, 
J = 10.0 Hz, 3 or 4-H), 5.81 (1H, t, J = 10.0 Hz, 3 or 4-H), 6.89 (1H, s, Valoneoyl-H), 7.12 (2H, s, 
Galloyl-H), 7.13 (1H, s, Valoneoyl-H), 7.20 (2H, s, Galloyl-H), 7.30 (1H, s, Valoneoyl-H), 9.42 (1H, s, 
CHO), glu-5-H was hidden by OMe signals; 13C-NMR (100 MHz, CDCl3) δ 52.2, 55.4, 55.5, 56.0, 56.2, 
56.2, 56.3, 60.6, 60.6, 60.9, 61.0, 61.0, 61.1, 61.2, 61.4, 65.2, 68.4, 68.9, 71.1, 72.4, 96.9, 97.0, 107.0, 
107.2, 108.4, 109.0, 109.4, 119.3, 122.5, 124.1, 124.2, 125.6, 129.3, 129.6, 142.4, 142.6, 142.7, 146.0, 
147.3, 147.5, 150.6, 151.7, 152.1, 153.0, 153.1, 153.1, 165.0, 165.2, 165.5, 165.7, 190.4; HRMS (FAB, 
positive ion mode) calculated for C59H69O28 [M+H]+ : 1225.3975; found : 1225.3989 [M+H]+. To a 
solution of the above aldehyde (642 mg, 0.524 mmol) in THF (6 mL) and tBuOH (6 mL), 2-methyl-2-
butene (0.557 mL, 5.24 mmol) was added at room temperature. To the mixture, a solution of 80% 
NaClO2 (178 mg, 1.57 mmol) and NaH2PO4･2H2O (409 mg, 2.62 mmol) in H2O (6 mL) was dropwise 
added. After stirring for 2 h, the reaction mixture was poured into H2O (50 mL) and extracted with Et2O 
(50 mL×3). The combined organic layer was washed with brine (50 mL), dried over MgSO4, and 
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filtrated. The filtrate was evaporated and the colorless residue (711 mg) was purified by silica gel 
column chromatography (1 : 14 : 14 ; EtOH : EtOAc : CHCl3), providing 34 (650 mg, quant) as a 
colorless amorphous: [α]D25 = +41.6° (c = 0.61, CHCl3); IR (CHCl3) υmax 3030, 3010, 2940, 2840, 1730, 
1590, 1505, 1490, 1460, 1430, 1420, 1390, 1340, 1230, 1175, 1130, 1085, 1030, 1000, 920, 860, 670 
cm-1; 1H-NMR (400 MHz, CDCl3) δ 3.31 (1H, dd, B of ABX, J = 8.0, 10.8 Hz, 6-H), 3.38 (3H, s, OMe), 
3.43 (3H, s, OMe), 3.47 (3H, s, OMe), 3.52 (3H, s, OMe), 3.66 (1H, dd, A of ABX, J = 1.2, 10.8 Hz, 6-
H), 3.77 (3H, s, OMe), 3.780 (3H, s, OMe), 3.782 (6H, s, OMe), 3.81 (3H, s, OMe), 3.856 (3H, s, OMe), 
3.862 (6H, s, OMe), 3.90 (3H, s, OMe), 3.92 (3H, s, OMe), 3.94(3H, s, OMe), 3.97 (3H, s, OMe), 4.06 
(3H, s, OMe), 4.63 (1H, d, B of AB, J = 6.8 Hz, OCHAHBOMe), 4.69 (1H, d, A of AB, J = 6.8 Hz, 
OCHAHBOMe), 5.08 (1H, dd, J = 3.2, 10.0 Hz, 2-H), 5.17 (1H, t, J = 10.0 Hz, 3 or 4-H), 5.24 (1H, d, J 
= 3.2 Hz, 1-H), 6.02 (1H, t, J = 10.0 Hz, 3 or 4-H), 7.05 (1H, s, Valoneoyl-H), 7.09 (2H, s, Galloyl-H), 
7.15 (1H, s, Valoneoyl-H), 7.23 (2H, s, Galloyl-H), 7.28 (1H, s, Valoneoyl-H), glu-5-H overlapped with 
OMe signals; 13C-NMR (100 MHz, CDCl3) δ 52.3, 55.3, 55.5, 55.9, 56.2, 56.2, 56.3, 60.4, 60.6, 60.9, 
60.9, 61.0, 61.1, 61.2, 61.3, 66.5, 68.6, 69.0, 70.9, 72.5, 96.4, 97.0, 107.0, 107.2, 108.8, 109.0, 112.8, 
119.4, 123.3, 123.7, 124.1, 124.2, 127.1, 127.8, 142.6, 142.7, 142.7, 146.1, 146.2, 147.2, 147.3, 150.4, 
151.4, 151.8, 152.0, 152.1, 153.0, 153.1, 165.0, 165.7, 165.7, 165.9, 167.1; HRMS (FAB, positive ion 
mode) calculated for C59H69O29 [M+H]+ : 1241.3924; found : 1241.3931 [M+H]+. 
All-methylated rugosin B (Hexadecamethyl derivative of rugosin B) (3). To a solution of 34 (150 
mg, 0.121 mmol) in THF (7.5 mL) and MeOH (7.5 mL), 6N HCl aq. (15 mL) was added at 0°C. After 
stirring for 12 h at room temperature, the reaction mixture was extracted with Et2O (50 mL×3) and the 
combined organic layer was washed with brine (50 mL), dried over MgSO4, and filtrated. The filtrate 
was evaporated and the obtained residue (159 mg) was used in the next reaction without further 
purification. To a solution of the prepared material in CH2Cl2 (121 ml), EDC (928 mg, 4.84 mmol) and 
DMAP (296 mg, 2.42 mmol) were added at room temperature. The reaction mixture was stirred for 2.5 
day under N2 atmosphere, it was poured into H2O (80 mL) and extracted with with CH2Cl2 (100 mL×3). 
The combined organic layer was washed with brine (50 mL), dried over MgSO4, and filtrated. The 
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filtrate was evaporated and the resulting residue (441 mg) was purified by silica gel column 
chromatography (1 : 1 ; EtOAc : hexane), providing all-methylated rugosin B (3) (89.9 mg, 63%) as a 
colorless amorphous: [α]D25 = +68.0° (c = 1.16, acetone); 1H-NMR (400 MHz, acetone-d6) δ 3.44 (3H, s, 
OMe), 3.68 (3H, s, OMe), 3.71 (3H, s, OMe), 3.74 (3H, s, OMe), 3.77 (3H, s, OMe), 3.78 (6H, s, OMe), 
3.79 (3H, s, OMe), 3.81 (3H, s, OMe), 3.84 (3H, s, OMe), 3.87 (9H, s, OMe), 3.96 (6H, s, OMe), 4.04 
(3H, s, OMe), 4.48 (1H, ddd, J = 1.2, 6.4, 10.0 Hz, 5-H), 5.12 (1H, dd, J = 4.0, 10.0 Hz, 2-H), 5.169 (1H, 
dd, A of ABX, J = 6.4, 13.2 Hz, 6-H), 5.170 (1H, t, J = 10.0 Hz, 4-H), 5.26 (1H, d, J = 4.0 Hz, 1-H), 
5.85 (1H, t, J = 10.0 Hz, 3-H), 6.52 (1H, s, Valoneoyl-H), 6.79 (1H, s, Valoneoyl-H), 7.27 (2H, s, 
Galloyl-H), 7.28 (2H, s, Galloyl-H), 7.32 (1H, s, Valoneoyl-H), glu-6’-H overlapped with OMe signals; 
13C-NMR (100 MHz, acetone-d6) δ 52.5, 55.9, 56.4, 56.5, 56.6, 60.6, 60.7, 61.0, 61.0, 61.1, 61.2, 61.3, 
61.7, 64.1, 67.5, 71.3, 72.2, 73.8, 98.3, 106.7, 108.1, 108.1, 109.3, 109.5, 120.6, 123.5, 124.1, 125.0, 
125.3, 129.2, 129.6, 142.9, 143.8, 144.0, 145.0, 145.5, 148.0, 148.3, 151.7, 153.5, 153.8, 153.9, 154.2, 
154.3, 154.3, 165.9, 166.0, 166.5, 167.8, 167.9; HRMS (FAB, positive ion mode) calculated for 
C57H63O27 [M+H]+ : 1179.3557; found : 1179.3579 [M+H]+. 
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